MIR302CHG and breast cancer: Huang Z et al. [270] identified eight m7G-related lncRNAs (BAIAP2-DT, COL4A2-AS1, FARP1-AS1, RERE-AS1, NDUFA6-DT, TFAP2A-AS1, LINC00115, and MIR302CHG) and Cao J et al. [271] nine m7G-related lncRNAs (LINC01871, AP003469.4, Z68871.1, AC245297.3, EGOT, TFAP2A-AS1, AL136531.1, SEMA3B-AS1, AL606834.2), which could serve as potential biomarkers and therapeutic targets of BC.